These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 38541235)
1. Sacral Neuromodulation: Device Improvement and Current Applications in Urology. Spilotros M; Gerbasi S; Lasorsa F; de Rienzo G; Balducci L; Ditonno P; Lucarelli G Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541235 [TBL] [Abstract][Full Text] [Related]
2. [Sacral neuromodulation in urology. The emperor's new clothes or effective high-tech medicine?]. Hoda MR; Fornara P Urologe A; 2010 Oct; 49(10):1254-9. PubMed ID: 20859609 [TBL] [Abstract][Full Text] [Related]
3. [Sacral neuromodulation in under- and overactive detrusor-quo vadis? : Principles and developments]. Girtner F; Burger M; Mayr R Urologe A; 2019 Jun; 58(6):634-639. PubMed ID: 31139864 [TBL] [Abstract][Full Text] [Related]
4. [Invasive neurostimulation in neuro-urology: state of the art]. Kurze I; Böthig R; van Ophoven A Aktuelle Urol; 2024 Aug; 55(4):351-364. PubMed ID: 38631373 [TBL] [Abstract][Full Text] [Related]
5. An overview of sacral neuromodulation: a treatment for patients with symptoms of lower urinary tract dysfunction. Fletcher N Br J Nurs; 2020 Aug; 29(15):848-856. PubMed ID: 32790556 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of sacral neuromodulation on urological diseases: a multicentric research project. Cardarelli S; D'Elia C; Cerruto MA; Curti P; Ostardo E; Signorello D; Pastorello M; Caleffi G; Molon A; Artibani W Urologia; 2012; 79(2):90-6. PubMed ID: 22610844 [TBL] [Abstract][Full Text] [Related]
7. The role of neuromodulation in patients with neurogenic overactive bladder. Lay AH; Das AK Curr Urol Rep; 2012 Oct; 13(5):343-7. PubMed ID: 22865208 [TBL] [Abstract][Full Text] [Related]
8. Onset of Action of Sacral Neuromodulation in Lower Urinary Tract Dysfunction-What is the Optimal Duration of Test Stimulation? Jairam R; Drossaerts J; Marcelissen T; van Koeveringe G; van Kerrebroeck P J Urol; 2018 Jun; 199(6):1584-1590. PubMed ID: 29291416 [TBL] [Abstract][Full Text] [Related]
9. Sacral neuromodulation for the treatment of overactive bladder: systematic review and future prospects. Tilborghs S; De Wachter S Expert Rev Med Devices; 2022 Feb; 19(2):161-187. PubMed ID: 35061951 [TBL] [Abstract][Full Text] [Related]
10. Role of sacral neuromodulation in modern urogynaecology practice: a review of recent literature. Tahseen S Int Urogynecol J; 2018 Aug; 29(8):1081-1091. PubMed ID: 29302716 [TBL] [Abstract][Full Text] [Related]
11. [Sacral neuromodulation for neurogenic bladder dysfunction]. Kessler TM; Wöllner J; Kozomara M; Mordasini L; Mehnert U Urologe A; 2012 Feb; 51(2):179-83. PubMed ID: 22269992 [TBL] [Abstract][Full Text] [Related]
12. Outcomes in a contemporary cohort undergoing sacral neuromodulation using optimized lead placement technique. Adelstein SA; Lee W; Gioia K; Moskowitz D; Stamnes K; Lucioni A; Kobashi KC; Lee UJ Neurourol Urodyn; 2019 Aug; 38(6):1595-1601. PubMed ID: 31044466 [TBL] [Abstract][Full Text] [Related]
13. Implementation of sacral neuromodulation for urinary indications. A Danish prospective study during the initial 15 months of a new service in a tertiary referral hospital. Kobberø H; Andersen M; Andersen K; Pedersen TB; Poulsen MH Scand J Urol; 2022; 56(5-6):404-411. PubMed ID: 36085579 [TBL] [Abstract][Full Text] [Related]
14. Sacral neuromodulation treatment for urinary voiding dysfunctions: results of treatment with the largest single-center series in a tertiary referral center in Turkey. Kütükoğlu MU; Altuntaş T; Şahin B; Onur AR Turk J Med Sci; 2023 Feb; 53(1):206-210. PubMed ID: 36945940 [TBL] [Abstract][Full Text] [Related]
15. Optimal Lead Positioning in Sacral Neuromodulation: Which Factors Are Related to Treatment Outcome? Jairam R; Marcelissen T; van Koeveringe G; van Kerrebroeck P Neuromodulation; 2017 Dec; 20(8):830-835. PubMed ID: 28877395 [TBL] [Abstract][Full Text] [Related]
16. Sacral nerve stimulation for neuromodulation of the lower urinary tract. Oerlemans DJ; van Kerrebroeck PE Neurourol Urodyn; 2008; 27(1):28-33. PubMed ID: 17563110 [TBL] [Abstract][Full Text] [Related]
17. The value of urodynamic tools to guide patient selection in sacral neuromodulation. Drossaerts J; Rademakers K; van Koeveringe G; Van Kerrebroeck P World J Urol; 2015 Nov; 33(11):1889-95. PubMed ID: 25680936 [TBL] [Abstract][Full Text] [Related]
18. Bullseye Technique to Optimize S3 Foramen Access: Applying a Trusted Endourology Technique to Pelvic Medicine. Liem SS; Demus T; Jivanji D; Palmerola R Urology; 2023 Jan; 171():252-254. PubMed ID: 36334773 [TBL] [Abstract][Full Text] [Related]
19. Affective symptoms and quality of life in patients with voiding or storage dysfunction: Results before and after sacral neuromodulation: A prospective follow-up study. Jairam R; Drossaerts J; Vrijens D; Leue C; van Kerrebroeck P; van Koeveringe G Neurourol Urodyn; 2018 Jun; 37(5):1801-1808. PubMed ID: 29504634 [TBL] [Abstract][Full Text] [Related]